Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Assel M et al. |
A Four-kallikrein Panel and ß-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.
|
|
2 |
Booth N et al. |
Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data.
|
|
3 |
Caetano Dos Santos F et al. |
VASIM: an automated tool for the quantification of carotid atherosclerosis by computed tomography angiography.
|
|
4 |
Carlsson S et al. |
Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
|
|
5 |
Fizazi K et al. |
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
|
|
6 |
Hackman G et al. |
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
|
|
7 |
Horwich A et al. |
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
|
|
8 |
Hugosson J et al. |
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.
|
|
9 |
Häkkinen MR et al. |
Simultaneous analysis by LC-MS/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue.
|
|
10 |
Jambor I et al. |
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.
|
|
11 |
Joentausta R, Murtola T. |
Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.
|
|
12 |
Joentausta R et al. |
Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
|
|
13 |
Kaipia A. |
Erektio ja hermostollinen säätely.
|
|
14 |
Kaipia A. |
Erektiohäiriössä käytettävät lääkeaineet.
|
|
15 |
Khan J et al. |
Lower incidence of late tamponade after cardiac surgery by extended chest tube drainage.
|
|
16 |
Kiiski J et al. |
Transverse myocutaneous gracilis flap reconstruction is feasible after pelvic exenteration: 12-year surgical and oncological results.
|
|
17 |
Kiiski J et al. |
Tranverse myocutaneus gracilis flap reconstruction is feasible after pelvic exenteration: 12-year surgical and oncological results.
|
|
18 |
Kinnunen PT et al. |
Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer.
|
|
19 |
Knaapila J et al. |
Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
|
|
20 |
Knuuttila E et al. |
Access and concentrations of atorvastatin in the prostate in men with prostate cancer.
|
|
21 |
Kukko V et al. |
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.
|
|
22 |
Li-Sheng Chen S et al. |
Risk Prediction of Prostate Cancer with Single Nucleotide Polymorphisms and Prostate Specific Antigen.
|
|
23 |
Lindberg A et al. |
Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancer.
|
|
24 |
Lindström I et al. |
Psoas Muscle Area and Quality Are Independent Predictors of Survival in Patients Treated for Abdominal Aortic Aneurysms.
|
|
25 |
Linnanmäki L. |
The Biomechanical Properties of Flexor Tendon Repairs.
|
|
26 |
Murtola T et al. |
Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
|
|
27 |
Murtola T et al. |
Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Teemu J. Murtola, Heimo Syvälä, Teemu Tolonen, et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind....
|
|
28 |
Murtola T et al. |
Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer.
|
|
29 |
Murtola TJ, Veitonmäki T. |
Aspirin and Prostate Cancer Mortality: The Role of Tumor Grading Misclassification?
|
|
30 |
Nissinen SI et al. |
Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis.
|
|
31 |
Nuotio M et al. |
Elevated post-void residual volume in a geriatric post-hip fracture assessment in women-associated factors and risk of mortality.
|
|
32 |
Nurminen P et al. |
Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment.
|
|
33 |
Oksala N et al. |
Pre-Operative Masseter Area is an Independent Predictor of Long-Term Survival after Carotid Endarterectomy.
|
|
34 |
Pakarainen T et al. |
The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC).
|
|
35 |
Peltokangas M et al. |
Lower Limb Pulse Rise Time as a Marker of Peripheral Arterial Disease.
|
|
36 |
Pelttari S et al. |
Pseudoxanthoma elasticum - pyrofosfaatin puutostauti.
|
|
37 |
Pesonen J. |
Course and Consequences of Nocturia.
|
|
38 |
Pylväläinen J et al. |
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time.
|
|
39 |
Rantalaiho I et al. |
Acute kidney injury following hip fracture.
|
|
40 |
Riikonen JM et al. |
Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis.
|
|
41 |
Saarimäki L et al. |
Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer Centres.
|
|
42 |
Santala E et al. |
Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland - A nationwide cohort study.
|
|
43 |
Santala EE et al. |
Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
|
|
44 |
Schumacher FR et al. |
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
|
|
45 |
Shore N et al. |
Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS
Trial.
|
|
46 |
Siltari A et al. |
Effects of Preoperative Atorvastatin Treatment On Erectile Function After Radical Prostatectomy: Results From a Subgroup of ESTO1, a Randomized, Double-Blind, Placebo-Controlled Study.
|
|
47 |
Sujenthiran A et al. |
Is Nonoperative Management the Best First-line Option for High-grade Renal trauma? A Systematic Review.
|
|
48 |
Sutinen M et al. |
Identification of breast tumors from diathermy smoke by differential ion mobility spectrometry.
|
|
49 |
Sutinen M et al. |
Identification of breast tumors from diathermy smoke by differential ion mobility spectrometry.
|
|
50 |
Syyli N et al. |
Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study.
|
|
51 |
Talvitie A et al. |
Factors related to self-rated health and life satisfaction one year after radical prostatectomy for localised prostate cancer: a cross-sectional survey.
|
|
52 |
Vakhitov D et al. |
Survival of Patients and Treatment-Related Outcome After Intra-Arterial Thrombolysis for Acute Lower Limb Ischemia.
|
|
53 |
Vandekerkhove G et al. |
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
|
|
54 |
Veskimäe E et al. |
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of
Urology .
|
|
55 |
Åkerla J et al. |
Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish men.
|
|
56 |
Østergren P et al. |
Are Biomarker-driven Inclusion and Symptom Control Endpoints the Future of Phase 3 Trials in Metastatic Castration-resistant Prostate Cancer? Lessons from COMET-2.
|